Astrazeneca (AZNCF) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Astrazeneca (AZNCF) over the last 16 years, with Q4 2025 value amounting to -$6.15.
- Astrazeneca's Times Interest Earned fell 2964.59% to -$6.15 in Q4 2025 from the same period last year, while for Dec 2025 it was -$8.06, marking a year-over-year decrease of 4028.8%. This contributed to the annual value of -$8.11 for FY2025, which is 4128.17% down from last year.
- As of Q4 2025, Astrazeneca's Times Interest Earned stood at -$6.15, which was down 2964.59% from -$8.26 recorded in Q3 2025.
- In the past 5 years, Astrazeneca's Times Interest Earned ranged from a high of $70.19 in Q1 2021 and a low of -$10.53 during Q1 2025
- Over the past 5 years, Astrazeneca's median Times Interest Earned value was -$4.68 (recorded in 2024), while the average stood at -$0.75.
- In the last 5 years, Astrazeneca's Times Interest Earned surged by 200995.75% in 2021 and then tumbled by 44968.04% in 2022.
- Astrazeneca's Times Interest Earned (Quarter) stood at $0.87 in 2021, then crashed by 449.68% to -$3.04 in 2022, then grew by 8.75% to -$2.77 in 2023, then tumbled by 71.15% to -$4.75 in 2024, then dropped by 29.65% to -$6.15 in 2025.
- Its Times Interest Earned was -$6.15 in Q4 2025, compared to -$8.26 in Q3 2025 and -$7.99 in Q2 2025.